Skip to main content
Erschienen in: Archives of Virology 11/2014

01.11.2014 | Original Article

Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758

verfasst von: Qian Yang, Suzhen Fu, Jie Wang

Erschienen in: Archives of Virology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Chronic infection with hepatotropic viruses is the main cause of chronic liver disease and cirrhosis worldwide. Toll-like receptor 3 (TLR3) and Toll-like receptor 7 (TLR7) are pathogen-recognition receptors that are expressed on innate immune cells. They recognize viral RNA, which induces their activation, with a subsequent increase in type I interferon transcription. Hepatitis C virus (HCV) infection inhibits the expression of TLR3 and TLR7; however, the mechanism by which this occurs is unclear. MicroRNAs (miRNAs) are small RNAs that posttranscriptionally regulate gene expression. Their aberrant expression is commonly correlated with disease status, as is the case with HCV infection. Here, we found that miR-758 levels were increased in patients with HCV infection and were correlated with TLR3 and TLR7 expression levels in the patients with HCV infection, and bioinformatics analysis predicted that TLR3 and TLR7 are targets of miR-758. Therefore, we postulate that HCV may increase the level of miR-758, which inhibits the expression of TLR3 and TLR7, resulting in a loss of antiviral effect. In order to test our hypothesis, we constructed an HCV core protein expression plasmid and used it to transfect liver cells. The results showed that HCV infection increased miR-758 levels and decreased TLR3/TLR7 expression. Furthermore, using RT-PCR and luciferase reporter analysis, we found that miR-758 targets TLR3 and TLR7, with a subsequent decrease in IFNα and IFNβ production. In conclusion, our results highlight the upregulation of miR-758 expression by HCV as a novel mechanism contributing to downregulation of TLR3 and TLR7 in patients with HCV infection.
Literatur
1.
Zurück zum Zitat Benvegnu L, Gios M, Boccato S, Alberti A (2004) Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53:744–749PubMedCrossRefPubMedCentral Benvegnu L, Gios M, Boccato S, Alberti A (2004) Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53:744–749PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat Lok AS, Heathcote EJ, Hoofnagle YH (2001) Managment of hepatitis B: 2000—summary of a workshop. Gastroenterology 120:1828–1853PubMedCrossRef Lok AS, Heathcote EJ, Hoofnagle YH (2001) Managment of hepatitis B: 2000—summary of a workshop. Gastroenterology 120:1828–1853PubMedCrossRef
3.
Zurück zum Zitat (1999) EASL international consensus conference on hepatitis C: Paris, 26–28 February 1999 consensus statement. J Hepatol 30:956–961 (1999) EASL international consensus conference on hepatitis C: Paris, 26–28 February 1999 consensus statement. J Hepatol 30:956–961
4.
Zurück zum Zitat Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T (1999) Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 116:378–386PubMedCrossRef Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T (1999) Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 116:378–386PubMedCrossRef
5.
Zurück zum Zitat International Interferon-alfa Hepatocellular Carcinoma Study Group (1998) Effect of interferon-a on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 351:1535–1539CrossRef International Interferon-alfa Hepatocellular Carcinoma Study Group (1998) Effect of interferon-a on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 351:1535–1539CrossRef
6.
Zurück zum Zitat Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J (2000) Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32:1131–1137PubMedCrossRef Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J (2000) Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32:1131–1137PubMedCrossRef
7.
Zurück zum Zitat Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748PubMedCrossRef Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748PubMedCrossRef
8.
Zurück zum Zitat Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–1531PubMedCrossRef Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–1531PubMedCrossRef
9.
Zurück zum Zitat Mohammed KI, Adel LA, Ali-Eldin FA, Eladawy S (2013) Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha. Egypt J Immunol 20:13–22PubMed Mohammed KI, Adel LA, Ali-Eldin FA, Eladawy S (2013) Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha. Egypt J Immunol 20:13–22PubMed
10.
Zurück zum Zitat Sato K, Ishikawa T, Okumura A, Yamauchi T, Sato S, Ayada M, Matsumoto E, Hotta N, Oohashi T, Fukuzawa Y, Kakumu S (2007) Expression of Toll-like receptors in chronic hepatitis C virus infection. J Gastroenterol Hepatol 22(10):1627–1632PubMedCrossRef Sato K, Ishikawa T, Okumura A, Yamauchi T, Sato S, Ayada M, Matsumoto E, Hotta N, Oohashi T, Fukuzawa Y, Kakumu S (2007) Expression of Toll-like receptors in chronic hepatitis C virus infection. J Gastroenterol Hepatol 22(10):1627–1632PubMedCrossRef
11.
Zurück zum Zitat Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH (2013) Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther 18(7):877–884PubMedCrossRef Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH (2013) Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther 18(7):877–884PubMedCrossRef
12.
Zurück zum Zitat Roberts AP, Lewis AP, Jopling CL (2011) The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 102:101–139PubMedCrossRef Roberts AP, Lewis AP, Jopling CL (2011) The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 102:101–139PubMedCrossRef
13.
Zurück zum Zitat Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB (2013) Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology 58:863–871PubMedCrossRefPubMedCentral Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB (2013) Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology 58:863–871PubMedCrossRefPubMedCentral
14.
15.
18.
Zurück zum Zitat Sarnow P, Jopling CL, Norman KL, Schutz S, Wehner KA (2006) Micro-RNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol 4:651–659PubMedCrossRef Sarnow P, Jopling CL, Norman KL, Schutz S, Wehner KA (2006) Micro-RNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol 4:651–659PubMedCrossRef
19.
Zurück zum Zitat Conrad KD, Niepmann M (2013) The role of microRNAs in hepatitis C virus RNA replication. Arch Virol (Epub ahead of print) Conrad KD, Niepmann M (2013) The role of microRNAs in hepatitis C virus RNA replication. Arch Virol (Epub ahead of print)
20.
Zurück zum Zitat Ramirez CM, Dávalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suárez Y, Fernández-Hernando C (2011) MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31(11):2707–2714PubMedCrossRefPubMedCentral Ramirez CM, Dávalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suárez Y, Fernández-Hernando C (2011) MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31(11):2707–2714PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307–336PubMedCrossRef Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307–336PubMedCrossRef
Metadaten
Titel
Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758
verfasst von
Qian Yang
Suzhen Fu
Jie Wang
Publikationsdatum
01.11.2014
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 11/2014
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2167-3

Weitere Artikel der Ausgabe 11/2014

Archives of Virology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.